Background-Opening of cardiac ATP-sensitive K ϩ (K ATP ) channels has emerged as a promising but still controversial cardioprotective mechanism. Defining K ATP channel function at the level of recombinant channel proteins is a necessary step toward further evaluation of the cardioprotective significance of this ion conductance. Methods and Results-K ATP channel-deficient COS-7 cells were found to be vulnerable to chemical hypoxia-reoxygenation injury that induced significant cytosolic Ca 2ϩ loading (from 97Ϯ3 to 236Ϯ11 nmol/L). In these cells, the potassium channel opener pinacidil (10 mol/L) did not prevent Ca 2ϩ loading (from 96Ϯ3 nmol/L before to 233Ϯ12 nmol/L after reoxygenation) or evoked membrane current. Cotransfection with Kir6.2/SUR2A genes, which encode cardiac K ATP channel subunits, resulted in a cellular phenotype that, in the presence of pinacidil (10 mol/L), expressed K ϩ current and gained resistance to hypoxia-reoxygenation (Ca 2ϩ concentration from 99Ϯ7 to 127Ϯ11 nmol/L; PϾ0.05). Both properties were abolished by the K ATP channel blocker glyburide (1 mol/L). In COS-7 cells transfected with individual channel subunits Kir6.2 or SUR2A, which alone do not form functional cardiac K ATP channels, pinacidil did not protect against hypoxia-reoxygenation. Conclusions-The fact that transfer of cardiac K ATP channel subunits protected natively K ATP channel-deficient cells provides direct evidence that the cardiac K ATP channel protein complex harbors intrinsic cytoprotective properties. These findings validate the concept that targeting cardiac K ATP channels should be considered a valuable approach to protect the myocardium against injury. (Circulation. 1998;98:1548-1555.)
I
n recent years, targeting of cardiac ATP-sensitive K ϩ (K ATP ) channels, a metabolism-sensitive ion conductance, has emerged as a promising therapeutic strategy against ischemic injury in the myocardium. [1] [2] [3] [4] In particular, potassium channel openers, which promote opening of K ATP channels, have been found to decrease infarct size, mimic ischemic preconditioning, and improve functional and energetic recovery of cardiac muscle after ischemic and hypoxic insults. [1] [2] [3] [4] [5] [6] Moreover, in the majority of studies, antagonists of K ATP channels, such as the sulfonylurea drugs, abolished the beneficial effect of potassium channel openers, further implying a cardioprotective role for K ATP channels. 7, 8 However, in the absence of more direct evidence that channel proteins themselves are responsible for cardioprotection, this concept has been continuously contested, 9 -11 partly because of the complexity of regulation of K ATP channel behavior under ischemic conditions, as well as the difficulty in separating K ATP channel-dependent from K ATP channel-independent protective mechanisms that coexist within a cardiac cell. [12] [13] [14] [15] [16] [17] [18] [19] [20] In this regard, defining K ATP channel function at the level of recombinant channel proteins is a necessary step toward further evaluation of the cardioprotective significance of this ion channel.
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Proteins that constitute the K ATP channel complex have been cloned. [21] [22] [23] [24] Cardiac K ATP channels are heteromultimers composed of at least 2 structurally distinct subunits. The pore-forming inwardly rectifying K ϩ channel core, Kir6.2, is primarily responsible for K ϩ permeance, whereas the regulatory subunit, also known as the sulfonylurea receptor, or SUR2A, has been implicated in ligand-dependent channel gating. 23 Coexpression of Kir6.2 with SUR2A in a cell line devoid of endogenous K ATP channels reconstitutes basic electrophysiological and pharmacological properties of the native cardiac channel. 23, 25 However, it is not known whether expression of recombinant cardiac K ATP channel proteins also confers protection against cell injury.
We therefore took advantage of the COS cell line, which lacks native K ATP channels 22, 23 and is vulnerable to oxidative stress, to deliver genes encoding the 2 cardiac K ATP channel subunits Kir6.2 and SUR2A and examined the outcome of activation of heterologously expressed channel proteins on the cellular susceptibility toward hypoxia-reoxygenation. We report that activation of recombinant cardiac K ATP channels protects against hypoxia-reoxygenation-induced intracellular Ca 2ϩ loading and present direct evidence that Kir6.2 and SUR2A are both necessary and sufficient to confer cellular protection.
Methods

Untransfected and Transfected COS-7 Cells
COS-7 cells (ATCC) were cultured in a tissue flask (at 5% CO 2 ) containing DMEM supplemented with 10% FCS and 2 mmol/L glutamine. 26, 27 Cells were then trypsinized (5 minutes, 37°C) and plated (2ϫ10 6 to 6ϫ10 6 ) on a 35ϫ10-mm or 60ϫ15-mm culture dish containing 12-mm or 25-mm glass coverslips. Cells were left untransfected or were transfected 24 hours later. At 40% to 60% confluence, cells were transfected by use of 8 to 24 L lipofectamine (Gibco), with 2 to 6 g of total plasmid DNA (full-length Kir6.2 and/or SUR2A cDNA subcloned into the mammalian expression vector pcDNA3.1 ϩ ) and with 0.2 to 0.6 g of the reporter green fluorescent protein (GFP) gene (Gibco). 27 Kir6.2 was a gift from Dr S. Seino (Chiba University, Chiba, Japan). 22, 23 SUR2A was kindly provided by Dr Y. Kurachi (Osaka University, Osaka, Japan).
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Digital Epifluorescent Imaging
In a chamber constructed with a coverslip as its base, COS-7 cells were superfused with Tyrode's solution (in mmol/L: NaCl 136.5, KCl 5.4, CaCl 2 1.8, MgCl 2 0.53, glucose 5.5, and HEPES-NaOH 5.5; pH 7.4). Cells were loaded (for 30 minutes) with the esterified form of the Ca 2ϩ -sensitive fluorescent probe fluo-3 (5 mol/L fluo-3-AM, dissolved in DMSO plus pluronic acid; Molecular Probes). Before loading with fluo-3-AM, transfected cells were preselected on the basis of GFP fluorescence, and GFP-dependent fluorescence was digitally subtracted. COS-7 cells were imaged with a digital epifluorescence imaging system coupled to an inverted microscope (Zeiss Axiovert-135 TV) with a ϫ40 (numerical aperture, 1ϫ3) oilimmersion objective lens. A 100-W mercury lamp served as a source of light to excite fluo-3 at 488 nm. An excitation dichroic mirror with a cutoff of 510 nm and a long-pass emission filter with a cutoff of 520 nm were used to detect fluo-3 fluorescence with an intensified charge-coupled device (CCD) camera. Detected fluorescence was digitized with imaging software (Attoflor RatioVision, Atto Instruments). 
Electrophysiological Measurements
Fire-polished pipettes coated with Sylgard (resistance, 5 to 7 M⍀) were filled with "pipette solution" (in mmol/L: KCl 140, CaCl 2 1, MgCl 2 1, and HEPES-KOH 5; pH 7.3). COS-7 cells were superfused with Tyrode's solution, and the patch-clamp technique was applied in the cell-attached configuration. 30 Single-channel recordings were monitored on-line with a high-gain digital storage oscilloscope (VC-6025, Hitachi) and stored on tape with a PCM converter system (VR-10, Instrutech). Data were reproduced, low-pass filtered at 1 kHz (Ϫ3 dB) by a Bessel filter (Frequency Devices 902), sampled at 
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Chemical Hypoxia-Reoxygenation Injury COS-7 cells superfused with Tyrode's solution were exposed to 2 mmol/L 2,4-dinitrophenol (DNP), a metabolic poison that inhibits mitochondrial oxidative phosphorylation. After a 3-minute treatment, DNP was removed, and cells were reexposed to Tyrode's solution. This chemical hypoxia-reoxygenation protocol was conducted in the absence or presence of the potassium channel opener pinacidil, with and without the potassium channel blocker glyburide. Both drugs were dissolved in DMSO, which in its final concentration did not exceed 0.1%. At this concentration, DMSO did not affect Ca 2ϩ levels or channel activity.
Single Ventricular Cardiomyocytes
In a separate series of experiments, the same chemical hypoxia-reoxygenation protocol was applied to cardiomyocytes. Ventricular myocytes were dissociated from pentobarbital-anesthesized guinea pigs. 18, 19, 28 The heart was perfused (at 37°C) with medium 199 for 3 minutes, followed by Ca 2ϩ -EGTA-buffered low-Ca 2ϩ medium (pCaϭ7) for 80 seconds and low-Ca 2ϩ medium containing pronase E (8 mg/100 mL), proteinase K (1.7 mg/100 mL), BSA (0.1 g/100 mL), and 200 mol/L CaCl 2 . Ventricles were separated from atria and cut into small fragments in the low-Ca 2ϩ medium enriched with 200 mol/L CaCl 2 . Single cells were isolated by stirring the tissue (at 37°C) in a solution containing pronase E and proteinase K supplemented with collagenase (5 mg/10 mL). After 10 minutes, the first aliquot was removed, filtered through a nylon sieve, centrifuged for 60 seconds (at 300 rpm), and washed twice. Isolation continued for 2 to 3 such cycles. Rod-shaped cardiomyocytes with clear striations and smooth surfaces were imaged by digital epifluorescent microscopy as described above.
Statistical Analysis
Data are presented as meanϮSEM, with n representing the number of imaged fields or patched cells. Mean values were compared by Student's t test or by 1-way ANOVA. A value of PϽ0.05 was considered statistically significant.
Results
Hypoxia-Reoxygenation Induces Ca 2؉ Loading in Untransfected COS-7 Cells
At rest, COS-7 cells have a low cytosolic Ca 2ϩ concentration (97.2Ϯ3.1 nmol/L; nϭ23; Figure 1A to 1C). A 3-minute-long exposure to chemical hypoxia induced by the mitochondrial uncoupler DNP, followed by reoxygenation evoked by removal of DNP, produced rapid and significant Ca 2ϩ loading (236Ϯ11 nmol/L, nϭ23; PϽ0.01; Figure 1A to 1C).
Pinacidil Does Not Protect Untransfected COS-7
Cells Against Hypoxia-Reoxygenation-Induced Ca 2؉ Loading
The same hypoxia-reoxygenation insult also induced significant cytosolic Ca 2ϩ loading (from 96.2Ϯ3.0 nmol/L at rest to 233Ϯ12 nmol/L after reoxygenation, nϭ4; PϽ0.01) in the presence of the K ATP channel opener pinacidil (Figure 2A and  2B) . In untransfected COS-7 cells, pinacidil did not evoke significant membrane current (Figure 2C; nϭ14) . Figure 3 ). The Figure 4A ). Such a protective effect of pinacidil was not observed in cells transfected with Kir6.2 or SUR2A alone ( Figure 4A ). Accordingly, cytosolic Ca 2ϩ levels after hypoxiareoxygenation were significantly higher in cells transfected with Kir6.2 (237Ϯ11 nmol/L; nϭ4) or SUR2A (234Ϯ9 nmol/L; nϭ4) than in cells cotransfected with Kir6.2/SUR2A (127Ϯ11 nmol/L; nϭ4; PϽ0.01) ( Figure 4B and 4C) . In COS-7 cells cotransfected with Kir6.2/SUR2A and treated with pinacidil, Ca 2ϩ levels were not significantly different before (98.7Ϯ6.8 nmol/L; nϭ4) and after (127Ϯ11 nmol/L; nϭ4; PϾ0.05) hypoxia-reoxygenation ( Figure 4C) .
Hypoxia-Reoxygenation Induces
Pinacidil Protects COS-7 Cells Cotransfected With
The protective effect of pinacidil was abolished by the K ATP channel antagonist glyburide ( Figure 5A ). After hypoxiareoxygenation, in the presence of both pinacidil (10 mol/L) and glyburide (1 mol/L), cytosolic Ca 2ϩ levels increased significantly, from 97.1Ϯ5.6 to 239Ϯ8 nmol/L in COS-7 cells cotransfected with Kir6.2/SUR2A (nϭ4; PϽ0.01) (Figure 5B) . In cotransfected cells, 10 mol/L pinacidil evoked opening of K ϩ channels, which was inhibited by 1 mol/L glyburide ( Figure 5C ). Channel activity, expressed as NP o , was 0.1Ϯ0.3 at rest, 4.7Ϯ0.9 in the presence of pinacidil, and 0.8Ϯ0.5 in the presence of both pinacidil and glyburide ( Figure 5D ; nϭ4).
Pinacidil Also Protects Cardiomyocytes Against Hypoxia-Reoxygenation-Induced Ca 2؉ Loading
The same hypoxia-reoxygenation protocol also produced Ca 2ϩ loading (from 142Ϯ17 to 3856Ϯ289 nmol/L; nϭ4; PϽ0.01) in cardiomyocytes, which natively express K ATP channels ( Figure 6A and 6B) . Hypoxia-reoxygenation also induced cellular shortening (by 54Ϯ13%; nϭ4; Figure 6A to 6C). Treatment with pinacidil (100 mol/L) inhibited Ca 2ϩ loading (451Ϯ61 nmol/L in the presence compared with 3856Ϯ289 nmol/L in the absence of pinacidil; nϭ4; PϽ0.01; Figure 6A and 6B) and cellular shortening (nϭ4; Figure 6A to 6C). These effects of pinacidil were abolished by glyburide (10 mol/L). On average, in cardiomyocytes treated with pinacidil plus glyburide, cytosolic Ca 2ϩ was 139Ϯ18 nmol/L before and 4312Ϯ460 nmol/L after hypoxia-reoxygenation (nϭ4; PϽ0.01; Figure 6A and 6B), while cells concomitantly shortened by 43Ϯ12% (Figure 6A to 6C) . 
Discussion
In the present study, we show that coexpression of the recombinant cardiac K ATP channel subunits Kir6.2 and SUR2A confers resistance to intracellular Ca 2ϩ loading induced by hypoxia-reoxygenation. These findings indicate that the cardiac K ATP channel harbors cytoprotective properties inherent to the channel subunits themselves.
In recent years, use of recombinant channel proteins has proved to be a direct approach to determine intrinsic channel characteristics, independent of the cellular environment. [22] [23] [24] [25] [26] [27] Coexpression of Kir6.2/SUR2A has been found to reconstitute functional cardiac K ATP channels, in terms of single-channel conductance and gating properties. 23, 25 Here, we extended the use of recombinant channel proteins to determine the protective properties of cardiac K ATP channels intrinsic to constitutive channel subunits in the setting of hypoxia-reoxygenation injury.
Regardless of the cell type, it is well established that reoxygenation that follows a hypoxic insult initiates a series of cellular reactions leading to cell injury. 32 Studies in a number of tissues have also established that hypoxia-reoxygenation induces intracellular Ca 2ϩ loading, which represents a major indicator of the degree of cell injury. 32, 33 In COS-7 cells, which were used here, basal levels of cytosolic Ca 2ϩ , estimated by the intensity of fluo-3 fluorescence, were similar to those previously reported with other Ca 2ϩ -sensitive fluorescence probes, such as fura-2. 34 After hypoxia-reoxygenation, intracellular Ca 2ϩ concentration increased significantly, indicating that untransfected COS-7 cells are vulnerable to such an insult.
The potassium channel opener pinacidil was without effect on membrane ion currents or intracellular Ca 2ϩ loading in untransfected COS-7 cells, indicating that these cells lack a pinacidil-sensitive, K ATP channel-dependent protective mechanism. This is in accord with previous studies that have established COS-7 cells as a cell line devoid of endogenous K ATP channels and a reliable model to conduct studies on K ATP channel subunits. 22, 23, 26, 27 Transfection with Kir6.2 or SUR2A alone or cotransfection with Kir6.2/SUR2A did not protect, or protected only marginally, against hypoxia-reoxygenation. This is in line with previous findings that individual subunits do not form functional channels 23 and that only modest opening of the cardiac K ATP channel complex occurs within the time frame of metabolic stress used here. 23, 35 Alternatively, this could be interpreted to mean that within a noncardiac environment, constitutive K ATP channel proteins are without cytoprotective properties. It is established that protection afforded through a K ATP channel-dependent mechanism commonly occurs after channel activation by ischemic preconditioning or by potassium channel openers. [1] [2] [3] [4] In the present study, we promoted opening of recombinant cardiac K ATP channels with pinacidil, which has been established to effectively activate the cardiac isoform of the channel. 6, 23, 29 In COS-7 cells cotransfected with Kir6.2/SUR2A, pinacidil activated K ϩ current and prevented intracellular Ca 2ϩ loading induced by hypoxia-reoxygenation. Both pinacidil-induced K ϩ current and cellular protection were abolished by glyburide, an antagonist of K ATP channels, confirming that opening of recombinant K ATP channels is responsible for the observed cellular resistance to hypoxia-reoxygenation. Fur- thermore, pinacidil was without effect in cells transfected with Kir6.2 or SUR2A alone, which are insufficient to form functional K ATP channels. 23 Taken together, the present finding provides direct evidence that the cardiac K ATP channel complex is cytoprotective as a result of properties inherent to channel subunits themselves and that transfer of channel clones into a cell type lacking K ATP channels confers resistance to chemical hypoxia-reoxygenation injury when opened by a K ATP channel opener. Such a conclusion seems to be applicable to the myocardium itself, where Kir6.2 and SUR2A are naturally expressed, because we observed a similar response in cardiomyocytes exposed to the same experimental stress as cotransfected COS-7 cells.
The mechanism responsible for the K ATP channel subunit-dependent reduction of chemical hypoxia-reoxygenation-induced Ca 2ϩ loading is at present not known. In principle, several mechanisms underlying pinacidilinduced protection, including shortening of the action potential duration, hyperpolarization of the cell membrane, and targeting of mitochondrial K ATP channels, have been proposed. [1] [2] [3] [4] 11, 36 Although the participation of such mechanisms remains to be established, a mechanism that would involve shortening of the action potential duration is rather unlikely under the present experimental conditions, because pinacidil-mediated protection was observed in cells that did not generate action potentials. The fact that expression of recombinant cardiac K ATP channel subunits could transform COS-7 cells from a reoxygenation-vulnerable to a reoxygenation-resistant cellular phenotype supports the notion that K ATP channels may have a ubiquitous cytoprotective role. Activation of natively expressed K ATP channels not only in cardiac cells [1] [2] [3] [4] [5] [6] but also in other tissues, including the brain and skeletal muscle, has been associated with a protective outcome. 37, 38 Conversely, natively occurring or engineered mutations of K ATP channel subunits impair channel activity or its regulation with consequences on cell function and cell survival. 39, 40 In pancreatic ␤-cells, in which K ATP channels are critical for glucosemediated insulin secretion, disruption of native pancreatic K ATP channels in transgenic animals has been found to induce hypoglycemia, with hyperinsulinemia in neonates and hyperglycemia with hypoinsulinemia in adults, with a decrease in viable ␤-cells. 40 In humans, mutations in K ATP channel subunits have been linked to the syndrome of familial persistent hyperinsulinemic hypoglycemia of infancy, and mutations in SUR2 have been suggested as a candidate for a susceptibility gene in the clinical condition of brachydactyly with hypertension. 39 Thus, in addition to previously established deleterious consequences of mutations or disruptions in K ATP channels, the present study provides evidence that expression of recombinant cardiac K ATP channel subunits induces gain of cytoprotective function in cells lacking the ability to withstand injury.
In conclusion, this study provides direct evidence that the cardiac K ATP channel is cytoprotective by virtue of properties intrinsic to proteins constituting the channel complex and validates the concept that targeting myocardial K ATP channels should be considered a valuable approach aimed at protecting the hypoxic myocardium. Furthermore, the demonstration that K ATP channel subunit-dependent protection can be transferable may provide the framework for future therapeutic strategies based on gene delivery of channel subunits in states associated with K ATP channel deficiency.
